The FDA has given emergency use authorization to the University of Texas MD Anderson Cancer Center for its High-throughput SARS-CoV-2 RT-PCR Assay and to Diagnostic Solutions Laboratory for its DSL COVID-19 assay.
2 COVID-19 tests authorized for emergency use
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.